Your browser doesn't support javascript.
loading
COVID-19 vaccination coverage and intent among women aged 18-49 years by pregnancy status, United States, April-November 2021.
Razzaghi, Hilda; Yankey, David; Vashist, Kushagra; Lu, Peng-Jun; Kriss, Jennifer L; Nguyen, Kimberly H; Lee, James; Ellington, Sascha; Polen, Kara; Bonner, Kimberly; Jatlaoui, Tara C; Wilhelm, Elisabeth; Meaney-Delman, Dana; Singleton, James A.
Afiliación
  • Razzaghi H; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: HRazzaghi@cdc.gov.
  • Yankey D; Oak Ridge Institute for Science and Education, United States.
  • Vashist K; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States; Oak Ridge Institute for Science and Education, United States.
  • Lu PJ; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Kriss JL; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Nguyen KH; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Lee J; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Ellington S; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Center for Disease Control and Prevention, United States.
  • Polen K; Division of Birth Defects and Infant Disorders, National Center for Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Bonner K; Epidemic Intelligence Service, Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Jatlaoui TC; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Wilhelm E; Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Meaney-Delman D; Division of Birth Defects and Infant Disorders, National Center for Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Singleton JA; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Vaccine ; 40(32): 4554-4563, 2022 07 30.
Article en En | MEDLINE | ID: mdl-35725781

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cobertura de Vacunación / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cobertura de Vacunación / COVID-19 Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: Vaccine Año: 2022 Tipo del documento: Article Pais de publicación: Países Bajos